CanadaBis CapitalTSXV:CANB Interest Coverage is 0.45 as of Oct. 2025, which is 96% below its 10-year median of 10.49. The stock has 6 warning signs investors should review. Among 684 Drug Manufacturers companies, CanadaBis Capital ranks worse than 98.83% on this metric.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's
Operating Income
by its Interest Expense. CanadaBis Capital's
Operating Income
for the
three
months ended in Oct. 2025 was C$0.12 Mil. CanadaBis Capital's Interest Expense for the
three
months ended in Oct. 2025 was C$-0.26 Mil.
CanadaBis Capital's interest coverage for the quarter that ended in Oct. 2025 was 0.45.
The higher the ratio, the stronger the company's financial strength is.
Warning Sign:
Ben Graham prefers companies' interest coverage to be at least 5. CanadaBis Capital Incs earnings cannot cover its interest expense. If the situation continues, the company may have to issue more debt.
The historical rank and industry rank for CanadaBis Capital's Interest Coverage or its related term are showing as below:
TSXV:CANB'
s Interest Coverage Range Over the Past 10 Years
Min: 0.2 Med: 10.49 Max: No Debt
Current: 0.2
TSXV:CANB's Interest Coverage is ranked worse than 98.83% of 684
companies
in the Drug Manufacturers industry
Industry Median: 12.765
vs TSXV:CANB: 0.20
CanadaBis Capital (TSXV:CANB) Interest Coverage Explanation
Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.
Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .
CanadaBis Capital Interest Coverage Related Terms
CanadaBis Capital Interest Coverage Historical Data
* Premium members only.
The historical data trend for CanadaBis Capital's Interest Coverage can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
TSXV:CANB vs NPHC, BSPK, CPMD: Interest Coverage Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, CanadaBis Capital's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
CanadaBis Capital Interest Coverage vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, CanadaBis Capital's Interest Coverage distribution charts can be found below:
* The bar in red indicates where CanadaBis Capital's Interest Coverage falls into.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CanadaBis Capital (TSXV:CANB) has a Interest Coverage of 0.45 as of Oct. 2025. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on CanadaBis Capital and its competitors. This is 96% below median its historical median of 10.49. Over the past decade, CanadaBis Capital's Interest Coverage has ranged from 0.20 to 10,000.00. According to the industry distribution chart, CanadaBis Capital ranks #676 out of 684 companies in the Drug Manufacturers industry, placing it in the top 98.8%.
Is CanadaBis Capital's Interest Coverage too high?
CanadaBis Capital's current Interest Coverage of 0.45 is 96% below median its 10-year median of 10.49. Over the past 10 years, this metric has ranged from a low of 0.20 to a high of 10,000.00. The Drug Manufacturers industry median Interest Coverage is 12.77. CanadaBis Capital's value of 0.45 is 96.5% below this industry median. Based on the distribution chart, CanadaBis Capital ranks #676 out of 684 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers.
How does CanadaBis Capital's Interest Coverage compare to NPHC and BSPK?
According to the Drug Manufacturers industry distribution chart, CanadaBis Capital ranks #676 out of 684 companies for Interest Coverage. This places CanadaBis Capital in the lower half of its industry. The industry median Interest Coverage is 12.77. CanadaBis Capital's value of 0.45 is 96.5% below this benchmark. Historically, CanadaBis Capital's own Interest Coverage has ranged from 0.20 to 10,000.00 over the past decade. While the company's 10-year median is 10.49 vs. the industry median of 12.77, CanadaBis Capital has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Drug Manufacturers company?
The median Interest Coverage among Drug Manufacturers companies is 12.77, based on 684 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. CanadaBis Capital's current Interest Coverage of 0.45 is 96.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on CanadaBis Capital and its competitors. For the Drug Manufacturers industry, the median Interest Coverage is 12.77 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. CanadaBis Capital's current Interest Coverage is 0.45, which is 96% below median its own 10-year median of 10.49. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CanadaBis Capital stock overvalued right now?
CanadaBis Capital (TSXV:CANB) has a current Interest Coverage of 0.45. The stock's GF Value™ is C$0.07, compared to a current price of C$0.02 — trading 78.6% below its estimated fair value. The current Interest Coverage is 0.45, which is 96% below median its 10-year median of 10.49 and 96.5% below the Drug Manufacturers industry median of 12.77. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For CanadaBis Capital (TSXV:CANB), the current Interest Coverage is 0.45 as of Oct. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
CanadaBis Capital Inc is a vertically integrated cannabis company. The firm engages in the production and sale of recreational cannabis. Its product line consists of Stigma Roots. It operates in three segments: wholesale, retail, and extract. The wholesale segment cultivates and distributes cannabis and cannabis products to and through, provincial liquor and cannabis boards. Retail segment involves sale of cannabis and cannabis-related products to end consumers on-premises owned and operated by the Company. Extract segment provides cannabinoid extraction services to other licensed producers. The company generates maximum of its revenue from Extract Segment.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSXV:CANB has been successfully added to your 